Answers are grounded in this paper and cite their sources.
Estimates of individual patient risk, and epidemiologic studies assessing potential late effects, must use patient size–specific dose estimates—they cannot use only scanner output (volume CT dose index or dose-length product).
No takes yet. Share an insight, caveat, or question.
McCollough et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: